The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
K
|
Krystal Biotech Inc
SWB:4KB
|
US |
|
Geo Energy Resources Ltd
F:7GE
|
SG |
|
Baidu Inc
NASDAQ:BIDU
|
CN |
|
T
|
TS Trillion Co Ltd
KOSDAQ:317240
|
KR |
|
C
|
China State Construction International Holdings Ltd
XMUN:C4S1
|
HK |
|
S
|
SoftBank Group Corp
XMUN:SFT
|
JP |
|
Zignago Vetro SpA
MIL:ZV
|
IT |
|
C
|
China State Construction International Holdings Ltd
F:C4S1
|
HK |
|
W
|
Weyerhaeuser Co
SWB:WHC
|
US |
|
F
|
Fairvest Ltd
JSE:FTB
|
ZA |
|
China State Construction International Holdings Ltd
OTC:CCOHF
|
HK |
|
G
|
Geo Energy Resources Ltd
OTC:GRYRF
|
SG |
|
W
|
Weyerhaeuser Co
F:WHC
|
US |
|
A
|
Airbus SE
XHAM:AIR
|
NL |
|
U
|
United Parcel Service Inc
SWB:UPAB
|
US |
|
Airbus SE
OTC:EADSY
|
NL |
|
A
|
Airbus SE
XMUN:AIR
|
NL |
|
V
|
Victory Capital Holdings Inc
F:3PK
|
US |
|
Victory Capital Holdings Inc
NASDAQ:VCTR
|
US |
|
K
|
Krystal Biotech Inc
F:4KB
|
US |
|
A
|
Airbus SE
XMUN:AIRA
|
NL |
|
P
|
Pernod Ricard SA
F:PER
|
FR |
|
Cloudflare Inc
NYSE:NET
|
US |
|
T
|
Trinity Watthana PCL
SET:TNITY
|
TH |
Krystal Biotech Inc (4KB)’s 12-month stock price forecast through August 2027 has a consensus target of €363.32, implying 33% upside. The forecast is based on price targets from 13 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
4KB is 363.32 EUR with a low forecast of 255.43 EUR and a high forecast of 443.2 EUR.
The compound annual growth rate for Revenue over the next 8 years is 22%.
The compound annual growth rate for Gross Profit over the next 8 years is 22%.
The compound annual growth rate for Operating Income over the next 8 years is 31%.
The compound annual growth rate for Pre-Tax Income over the next 3 years is 44%.
The compound annual growth rate for Net Income over the next 8 years is 21%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Already have an account? Sign in
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more